Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008

NCT01953770 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

3000

Enrollment

OTHER

Sponsor class

Conditions

Childhood Acute Lymphoblastic Leukemia

Interventions

DRUG: PEG-L-asparaginase ind
DRUG: PEG-L-asparaginase cons
DRUG: E.coli L-asparaginase
DRUG: High-dose Methotrexate
DRUG: Low-dose Methotrexate
DRUG: Triple intrathecal therapy
RADIATION: Cranial irradiation
DRUG: Daunorubicin

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology